WO2012018329A1 - Film-forming composition for soft capsules - Google Patents

Film-forming composition for soft capsules Download PDF

Info

Publication number
WO2012018329A1
WO2012018329A1 PCT/US2010/044419 US2010044419W WO2012018329A1 WO 2012018329 A1 WO2012018329 A1 WO 2012018329A1 US 2010044419 W US2010044419 W US 2010044419W WO 2012018329 A1 WO2012018329 A1 WO 2012018329A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
film
capsule
forming composition
soft capsule
Prior art date
Application number
PCT/US2010/044419
Other languages
French (fr)
Inventor
Takuma Fujii
Masanori Nagura
Tohru Amemiya
Original Assignee
R.P. Scherer Technologies, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R.P. Scherer Technologies, Llc filed Critical R.P. Scherer Technologies, Llc
Priority to BR112013002721A priority Critical patent/BR112013002721B8/en
Priority to US13/814,168 priority patent/US20130189522A1/en
Priority to EP10855698.6A priority patent/EP2600849B1/en
Priority to CA2807314A priority patent/CA2807314C/en
Priority to KR1020127015423A priority patent/KR101288079B1/en
Priority to MX2013001311A priority patent/MX344742B/en
Priority to PCT/US2010/044419 priority patent/WO2012018329A1/en
Priority to AU2010358565A priority patent/AU2010358565B2/en
Priority to CN201080069480.7A priority patent/CN103228269B/en
Publication of WO2012018329A1 publication Critical patent/WO2012018329A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10Coating with edible coatings, e.g. with oils or fats
    • A23P20/105Coating with compositions containing vegetable or microbial fermentation gums, e.g. cellulose or derivatives; Coating with edible polymers, e.g. polyvinyalcohol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/732Starch; Amylose; Amylopectin; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991Coated

Definitions

  • the present invention relates to a film-forming composition for soft capsules suitably used for forming soft capsules and a soft capsule prepared using the composition.
  • Soft capsules have widely been employed in the fields of pharmaceutical preparations, cosmetics and foods.
  • gelatin has widely been used as a principal component for constituting the shell of such a soft capsule, and gelatin is mainly produced from the bone of cattle and the skin of swine.
  • a problem arises such that vegetarians, people of Islamic faith who cannot eat swine, and those of the sacred and inviolable, cannot consume a soft capsule containing such gelatin derived from cattle and/or swine.
  • gelatin produced from the bone of cattle there is a perception that there is the possibility of infection with bovine spongiform encephalopathy.
  • gelatin other than that derived from cattle and swine, suffers from problems such that the gelatin does not provide the desired strength required for forming a gelatin capsule and it may increase the production cost of the gelatin capsule as its cost is generally higher when compared with the gelatin derived from cattle and swine.
  • unmodified starch such as rice starch and corn starch
  • a gelling agent and/or a plasticizer suffers from a problem in that it has a high viscosity, and it would be difficult to blend the starch with a gelling agent and/or a plasticizer and that the workability thereof upon the production of capsules is accordingly impaired.
  • the strength of a capsule, prepared using corn starch which has been decomposed even to dextrin according to the enzyme treatment as one of the physical treatments to reduce the viscosity is quite low and accordingly, the resulting product (capsule) cannot be used. It further suffers from a problem in that the strength thereof is extremely reduced with the lapse of time.
  • the present invention has been completed on the basis of such a finding that acid-decomposed waxy corn starch, among a variety of starches, is suitable as a substitute for gelatin and that when combining waxy corn starch with a gelling agent and a plasticizer, a shell can be formed, which has excellent characteristic properties suitable for use in the preparation of a soft capsule.
  • the present invention provides a film-forming composition for use in the preparation of a soft capsule, which comprises (a) acid-decomposed waxy corn starch; (b) a gelling agent; and (c) a plasticizer.
  • the present invention also provides a soft capsule which comprises a shell formed from the foregoing composition and a capsule-filling material accommodated within the shell.
  • the present invention can provide a shell for soft capsules, which is completely free of any material derived from animals such as gelatin and a soft capsule which comprises the shell and capsule-filling material accommodated within the shell.
  • the soft capsule comprising the shell produced using the film-forming composition for soft capsules has excellent characteristic properties with respect to physical strength, disintegration ability, odor, taste, color and lack of stickiness or adhesion; it also has excellent stability with the lapse of time.
  • carrageenan as the gelling agent (b) would have an advantage in that a film having a strength sufficient for processing and forming into a capsule can be formed without using any metal salt (such as a sodium salt, a potassium salt or a calcium salt), which salts are in general required for the gelatinization of carrageenan.
  • metal salt such as a sodium salt, a potassium salt or a calcium salt
  • Corn can be divided into species of dent corn and waxy corn, but the starch derived from the corn belonging to the waxy corn species is the objective starch to be used in the present invention as the component (a).
  • the corn of the waxy species is also referred to as glutinous corn, and the starch derived therefrom is generally one which is free of any amylase and substantially comprises 100% amylopectin.
  • the acid-decomposed waxy corn starch used in the present invention includes acid hydrolyzed waxy corn starch and acid roasted or broiled waxy corn starch.
  • the acid-decomposed waxy corn starch suitable for use in the present invention can be made according to known processes or purchased from commercial sources.
  • the acid-decomposed waxy corn starch is, for instance, one obtained by adding an inorganic acid or an organic acid such as sulfuric acid, or an oxidizing agent such as sodium hypochlorite to the starch derived from the corn of the waxy species and then heating the resulting mixture at a temperature ranging from about 10 to about 160°C to thus partially decompose the starch structure.
  • an inorganic acid or an organic acid such as sulfuric acid, or an oxidizing agent such as sodium hypochlorite
  • those preferably used in the present invention are those having a content of carboxyl groups on the order of not higher than 0.1% by mass.
  • preferably used herein are those each having a viscosity ranging from about 5 to about 100 mPa ⁇ S, as determined at 80°C using a 20% by mass aqueous solution thereof.
  • the viscosity of the starch can be determined using a BM viscometer (VISCO-BM Model, available from TOKIMECH Co., Ltd.) and a rotor no. 1.
  • the acid-decomposed waxy corn starch is commercially available as, for instance, WS-10 (available from MATSUTANI Chemical Industry, Co., Ltd.).
  • Particularly preferred acid-decomposed waxy corn starches include those having a viscosity ranging from about 5 to about 50 mPa ⁇ S and more preferably about 10 to about 20 mPa ⁇ S, as determined under the foregoing conditions.
  • the amount of the acid-decomposed waxy corn starch as the component (a) used in the film-forming composition for soft capsules according to the present invention preferably ranges from about 10 to about 60% by mass and more preferably about 25 to about 60% by mass (on the basis of the dry mass of the composition or the mass thereof except for water).
  • Examples of the gelling agents as the component (b) used in the present invention are carrageenan (i- carrageenan, ⁇ -carrageenan and ⁇ -carrageenan), agar, gum arabic, gellan gum, native gellan gum, pullulan, pectin, glucomannan, locust bean gum, guar gum, geran gum, cellulose, konjak-derived gum, furcellaran, tara-derived (Japanese angelica), i- carrageenan, ⁇ -carrageenan and ⁇ -carrageenan), agar, gum arabic, gellan gum, native gellan gum, pullulan, pectin, glucomannan, locust bean gum, guar gum, geran gum, cellulose, konjak-derived gum, furcellaran, tara-derived (Japanese angelica
  • carrageenan i- carrageenan, ⁇ -carrageenan and ⁇ -carrageenan
  • agar gum arabic, gellan gum, native gellan gum, pullulan, pectin and glucomannan
  • gelling agents are i- carrageenan, ⁇ -carrageenan and mixtures thereof, among others.
  • the amount of the gelling agent used as the component (b) of the film-forming composition for soft capsules according to the present invention preferably ranges from about 8 to about 30% by mass and more preferably about 10 to about 24% by mass (on the basis of the dry mass of the composition or the mass thereof except for water).
  • plasticizers used in the composition of the present invention as the component (c) include glycerin, sorbitol, maltitol, propylene glycol, polyethylene glycol, sugar alcohol, lactitol, polyalkylene glycol, monosaccharides, disaccharides,
  • oligosaccharides isomalto-oligosaccharides, diethylene glycol, glycerol monoacetate, glycerol diacetate, glycerol triacetate, invert sugars, corn syrup and 1 ,2-propylene glycol, which may be used alone or in any combination of at least two of them.
  • preferably used herein include glycerin, sorbitol, maltitol, propylene glycol, polyethylene glycol, sugar alcohol, lactitol, polyalkylene glycol, monosaccharides, disaccharides, oligosaccharides and isomalto-oligo- saccharides, which may be used alone or in any combination of at least two of them.
  • plasticizer (c) are glycerin, sorbitol, polyethylene glycol and mixtures thereof.
  • the amount of the plasticizer as the component (c) used in the film-forming composition for soft capsules according to the present invention preferably ranges from about 5 to about 65% by mass, more preferably about 10 to about 60% by mass and particularly preferably about 15 to about 50% by mass (on the basis of the dry mass of the composition or the mass thereof except for water).
  • the film-forming composition for soft capsules according to the present invention may further comprise a buffering agent (d).
  • buffering agents are sodium salts, potassium salts and calcium salts, and the buffering agent (d) used in the invention is preferably sodium phosphate.
  • the amount of the buffering agent as the component (d) used in the film-forming composition for soft capsules according to the present invention preferably ranges from about 0.2 to about 5% by mass and more preferably about 1 to about 4% by mass (on the basis of the dry mass of the composition or the mass thereof except for water).
  • carrageenan is particularly preferably used as the gelling agent or the component (b) since this would permit the elimination of the need for any buffering agent such as sodium salts, potassium salts and calcium salts, which are in general required for the gelatinization of carrageenan.
  • the film-forming composition for soft capsules according to the present invention may further comprise, as optional components, other additives, for instance, a coloring agent such as a coloring dyestuff or a pigment, a perfume and/or a preservative.
  • a coloring agent such as a coloring dyestuff or a pigment
  • a perfume and/or a preservative it is preferred that the composition is completely free of gelatin.
  • the film-forming composition for soft capsules When forming a shell for soft capsules using the film-forming composition for soft capsules according to the present invention, it is suitable that water is added to and blended with the film-forming composition for soft capsules in an amount ranging from about 40 to about 110 parts by mass per 100 parts by mass of the film-forming composition, and the resulting blend is then formed into a shell according to the usual method in such a manner that the thickness of the shell is set at a level ranging from about 0.1 to about 1.0 mm. In this respect, it is also possible to form a seamless capsule with the use of the film-forming composition for soft capsules according to the present invention. Methods of making soft capsules are conventional and can readily be used with the film-forming composition of the present invention.
  • the soft capsule of the present invention may be filled with, for instance, a suspension or an oil as a capsule-filling material. One of ordinary skill in the art can readily determine a suitable fill material.
  • Example 3 In these Comparative Examples 3 to 5, the same procedures used in Example 1 were repeated except that cluster dextrin (derived from waxy corn; Comparative Example 3), enzyme-treated dextrin (Pinedex #100; Comparative Example 4) and enzyme-treated dextrin
  • Example 1 The capsules produced in Example 1 and Comparative Examples 3 to 5 were inspected for the film strength and the stability thereof with the lapse of time, according to the following methods.
  • Film Thickness About 0.5 mm (0.4 to 0.6 mm);
  • Burst Test Machine KIYA Type Hardness Meter (1600-E Type, available from Fujiwara Seisakusho, Ltd.) Disintegration Ability
  • Example 1 the capsules produced in Example 1 and Comparative Examples 3 to 5 were inspected for the characteristic properties such as the appearance of the soft capsules.
  • the results thus obtained are summarized in the following Table 5.
  • the soft capsule (Example 1) produced using the film-forming composition for soft capsules according to the present invention was found to be excellent in all of the properties tested, or the odor, taste, color and lack of clumping, while the capsule prepared in Comparative Example 3 gives out a strong odor of caramel and has a taste of caramel. Accordingly, a problem arises such that the odor of caramel may impair the palatability of the capsule when eating the same.
  • the capsule prepared in Comparative Example 4 suffers from such a problem that it has an insufficient transparency and appears to be dark, although it has weak odor and taste of caramel.
  • the capsule prepared in Comparative Example 5 has an insufficient transparency, appears to be dark. Further the capsules prepared in Comparative Example 5 are mutually adhered to one another strongly, causing clumping and a problem thus arises when packaging the same.
  • Example 2 The same procedures used in Example 1 were repeated except for using the composition specified in the following Table 6, or the film-forming composition for soft capsules used in Example 1, from which sodium phosphate as a buffering agent was removed, to thus form a soft capsule.
  • the present invention permits the production of a soft capsule with excellent physical strength without using sodium phosphate as a buffering agent. Moreover, when comparing the results listed in Table 3 with those listed in Table 7, it was found that the capsule prepared in Example 2 has a shorter opening time than that observed for the capsule prepared in Example 1 , and the former has an excellent disintegration rate, which is one of the advantages of the soft capsule.

Abstract

Provided herein is a film-forming composition for use in the preparation of a soft capsule, which comprises (a) acid-decomposed waxy corn starch; (b) a gelling agent; and (c) a plasticizer. A soft capsule comprising a shell produced using the film-forming composition disclosed herein has excellent characteristic properties with respect to physical strength, disintegration ability, odor, taste, color and lack of adhesion and also exhibits excellent stability with time.

Description

FILM-FORMING COMPOSITION FOR SOFT CAPSULES
SPECIFICATION
Technical Field
[0001] The present invention relates to a film-forming composition for soft capsules suitably used for forming soft capsules and a soft capsule prepared using the composition.
Background
[0002] Soft capsules have widely been employed in the fields of pharmaceutical preparations, cosmetics and foods. In this respect, gelatin has widely been used as a principal component for constituting the shell of such a soft capsule, and gelatin is mainly produced from the bone of cattle and the skin of swine. However, a problem arises such that vegetarians, people of Islamic faith who cannot eat swine, and those of the Hindu faith who believe that cattle are sacred and inviolable, cannot consume a soft capsule containing such gelatin derived from cattle and/or swine. [0003] Moreover, with respect to gelatin produced from the bone of cattle, there is a perception that there is the possibility of infection with bovine spongiform encephalopathy. Also, gelatin, other than that derived from cattle and swine, suffers from problems such that the gelatin does not provide the desired strength required for forming a gelatin capsule and it may increase the production cost of the gelatin capsule as its cost is generally higher when compared with the gelatin derived from cattle and swine.
[0004] On the other hand, there have been known vegetable soft capsules whose shells are formed without using gelatin (see, for instance, JP 2003-504326A, JP 2008-519075 A, and JP 2005- 176744 A). Such vegetable soft capsules are produced from components derived from plants and therefore, they never suffer from a problem attributable to the use of the gelatin derived from cattle and swine. Soft capsules prepared using gelatin, are in general insolubilized with the lapse of time resulting in slower disintegration of the shell and slower release or in some circumstances a failure to release the capsule contents. Contrary to this, the vegetable soft capsule has an advantage in that it sparingly causes any insolubilization with the lapse of time and has good physical stability. However, it was found that such a vegetable soft capsule suffers from a problem such that the workability or processability of the material derived from plants encountered when it is formed into a capsule is insufficient and that the strength of the shell produced from the same is likewise unsatisfactory.
[0005] More specifically, unmodified starch (such as rice starch and corn starch) suffers from a problem in that it has a high viscosity, and it would be difficult to blend the starch with a gelling agent and/or a plasticizer and that the workability thereof upon the production of capsules is accordingly impaired. In this connection, the strength of a capsule, prepared using corn starch which has been decomposed even to dextrin according to the enzyme treatment as one of the physical treatments to reduce the viscosity, is quite low and accordingly, the resulting product (capsule) cannot be used. It further suffers from a problem in that the strength thereof is extremely reduced with the lapse of time.
[0006] For this reason, the development of a vegetable capsule which possesses excellent characteristics both in the preparation of a soft capsule and in subsequent storage is very desirable.
SUMMARY OF THE INVENTION
[0007] It is an object of the present invention to provide a film-forming composition for the preparation of a soft capsule which mainly comprises a component other than gelatin.
DETAILED DESCRIPTION
[0008] The present invention has been completed on the basis of such a finding that acid-decomposed waxy corn starch, among a variety of starches, is suitable as a substitute for gelatin and that when combining waxy corn starch with a gelling agent and a plasticizer, a shell can be formed, which has excellent characteristic properties suitable for use in the preparation of a soft capsule.
[0009] More specifically, the present invention provides a film-forming composition for use in the preparation of a soft capsule, which comprises (a) acid-decomposed waxy corn starch; (b) a gelling agent; and (c) a plasticizer.
[0010] The present invention also provides a soft capsule which comprises a shell formed from the foregoing composition and a capsule-filling material accommodated within the shell.
[0011] The present invention can provide a shell for soft capsules, which is completely free of any material derived from animals such as gelatin and a soft capsule which comprises the shell and capsule-filling material accommodated within the shell. The soft capsule comprising the shell produced using the film-forming composition for soft capsules has excellent characteristic properties with respect to physical strength, disintegration ability, odor, taste, color and lack of stickiness or adhesion; it also has excellent stability with the lapse of time. In addition, the use of, in particular, carrageenan as the gelling agent (b) would have an advantage in that a film having a strength sufficient for processing and forming into a capsule can be formed without using any metal salt (such as a sodium salt, a potassium salt or a calcium salt), which salts are in general required for the gelatinization of carrageenan.
[0012] Corn can be divided into species of dent corn and waxy corn, but the starch derived from the corn belonging to the waxy corn species is the objective starch to be used in the present invention as the component (a). The corn of the waxy species is also referred to as glutinous corn, and the starch derived therefrom is generally one which is free of any amylase and substantially comprises 100% amylopectin. The acid-decomposed waxy corn starch used in the present invention includes acid hydrolyzed waxy corn starch and acid roasted or broiled waxy corn starch. The acid-decomposed waxy corn starch suitable for use in the present invention can be made according to known processes or purchased from commercial sources. The acid-decomposed waxy corn starch is, for instance, one obtained by adding an inorganic acid or an organic acid such as sulfuric acid, or an oxidizing agent such as sodium hypochlorite to the starch derived from the corn of the waxy species and then heating the resulting mixture at a temperature ranging from about 10 to about 160°C to thus partially decompose the starch structure. Among those preferably used in the present invention are those having a content of carboxyl groups on the order of not higher than 0.1% by mass. In addition, preferably used herein are those each having a viscosity ranging from about 5 to about 100 mPa · S, as determined at 80°C using a 20% by mass aqueous solution thereof. The viscosity of the starch can be determined using a BM viscometer (VISCO-BM Model, available from TOKIMECH Co., Ltd.) and a rotor no. 1. The acid-decomposed waxy corn starch is commercially available as, for instance, WS-10 (available from MATSUTANI Chemical Industry, Co., Ltd.).
[0013] Particularly preferred acid-decomposed waxy corn starches include those having a viscosity ranging from about 5 to about 50 mPa · S and more preferably about 10 to about 20 mPa · S, as determined under the foregoing conditions.
[0014] The amount of the acid-decomposed waxy corn starch as the component (a) used in the film-forming composition for soft capsules according to the present invention preferably ranges from about 10 to about 60% by mass and more preferably about 25 to about 60% by mass (on the basis of the dry mass of the composition or the mass thereof except for water).
[0015] Examples of the gelling agents as the component (b) used in the present invention are carrageenan (i- carrageenan, κ-carrageenan and λ-carrageenan), agar, gum arabic, gellan gum, native gellan gum, pullulan, pectin, glucomannan, locust bean gum, guar gum, geran gum, cellulose, konjak-derived gum, furcellaran, tara-derived (Japanese angelica
tree-derived) gum, alginic acid and tamarind gum, which may be used alone or in any combination of at least two of them. Among them, preferably used herein are carrageenan (i- carrageenan, κ-carrageenan and λ-carrageenan), agar, gum arabic, gellan gum, native gellan gum, pullulan, pectin and glucomannan, which may be used alone or in any combination of at least two of them. Particularly preferably used herein as the gelling agents are i- carrageenan, κ-carrageenan and mixtures thereof, among others.
[0016] The amount of the gelling agent used as the component (b) of the film-forming composition for soft capsules according to the present invention preferably ranges from about 8 to about 30% by mass and more preferably about 10 to about 24% by mass (on the basis of the dry mass of the composition or the mass thereof except for water).
[0017] Examples of the plasticizers used in the composition of the present invention as the component (c) include glycerin, sorbitol, maltitol, propylene glycol, polyethylene glycol, sugar alcohol, lactitol, polyalkylene glycol, monosaccharides, disaccharides,
oligosaccharides, isomalto-oligosaccharides, diethylene glycol, glycerol monoacetate, glycerol diacetate, glycerol triacetate, invert sugars, corn syrup and 1 ,2-propylene glycol, which may be used alone or in any combination of at least two of them. Among them, preferably used herein include glycerin, sorbitol, maltitol, propylene glycol, polyethylene glycol, sugar alcohol, lactitol, polyalkylene glycol, monosaccharides, disaccharides, oligosaccharides and isomalto-oligo- saccharides, which may be used alone or in any combination of at least two of them. Particularly preferably used herein as the plasticizer (c) are glycerin, sorbitol, polyethylene glycol and mixtures thereof.
[0018] The amount of the plasticizer as the component (c) used in the film-forming composition for soft capsules according to the present invention preferably ranges from about 5 to about 65% by mass, more preferably about 10 to about 60% by mass and particularly preferably about 15 to about 50% by mass (on the basis of the dry mass of the composition or the mass thereof except for water).
[0019] The film-forming composition for soft capsules according to the present invention may further comprise a buffering agent (d). Examples of such buffering agents are sodium salts, potassium salts and calcium salts, and the buffering agent (d) used in the invention is preferably sodium phosphate.
[0020] The amount of the buffering agent as the component (d) used in the film-forming composition for soft capsules according to the present invention preferably ranges from about 0.2 to about 5% by mass and more preferably about 1 to about 4% by mass (on the basis of the dry mass of the composition or the mass thereof except for water).
[0021] In the present invention, however, carrageenan is particularly preferably used as the gelling agent or the component (b) since this would permit the elimination of the need for any buffering agent such as sodium salts, potassium salts and calcium salts, which are in general required for the gelatinization of carrageenan. In this case, it is preferred to use the acid-decomposed waxy corn starch (a) and the gelling agent (b) in a ratio [(a)/(b)] (by mass) ranging from about 1/1 to about 4/1.
[0022] In addition, the film-forming composition for soft capsules according to the present invention may further comprise, as optional components, other additives, for instance, a coloring agent such as a coloring dyestuff or a pigment, a perfume and/or a preservative. In this respect, however, it is preferred that the composition is completely free of gelatin.
[0023] When forming a shell for soft capsules using the film-forming composition for soft capsules according to the present invention, it is suitable that water is added to and blended with the film-forming composition for soft capsules in an amount ranging from about 40 to about 110 parts by mass per 100 parts by mass of the film-forming composition, and the resulting blend is then formed into a shell according to the usual method in such a manner that the thickness of the shell is set at a level ranging from about 0.1 to about 1.0 mm. In this respect, it is also possible to form a seamless capsule with the use of the film-forming composition for soft capsules according to the present invention. Methods of making soft capsules are conventional and can readily be used with the film-forming composition of the present invention. [0024] The soft capsule of the present invention may be filled with, for instance, a suspension or an oil as a capsule-filling material. One of ordinary skill in the art can readily determine a suitable fill material.
[0025] The present invention will hereunder be described in more detail with reference to the following examples and comparative examples, but the present invention is not restricted to these specific examples at all.
EXAMPLES
[0026] In the following Table 1, there are listed starches and the components related thereto, which are used in the following examples and comparative examples.
Table 1 :
Figure imgf000009_0001
[0027] These starch products are all commercially available from MATSUTANI Chemical Industry Co., Ltd., Ezaki Glico Co., Ltd. and Nippon Corn Starch Mfg. Co., Ltd.
[0028] The viscosity of the acid-decomposed waxy corn starch WS-10 was determined according to the following method:
[0029] To 80 g of starch (WS-10), there was added 320 g of pure water; the mixture was immersed in a warm water bath maintained at 80°C to thus dissolve the starch in water and to obtain a 20% aqueous starch solution. The temperature of the starch was maintained at 80°C, while the solution was still immersed in the warm water bath and the viscosity was determined by the use of a BM viscometer (VISCO-BM Model available from TOKIMECH Co., Ltd. connected to a rotor no. 1. As a result, the viscosity thereof was found to be 12 to 16 mPa · S.
Example 1
[0030] To the film-forming composition for soft capsules having the composition specified in the following Table 2, there was added pure water in an amount ranging from 40 to 110 parts by mass per 100 parts by mass of the composition to adjust the viscosity of the solution to a level sufficient for forming a capsule. Then a soft capsule was prepared from the resulting blend using a rotary die type encapsulation machine, while filling the resulting capsule with rapeseed oil as a capsule-filling material.
Table 2
Figure imgf000010_0001
Comparative Examples 1 and 2
[0031] In these Comparative Examples 1 and 2, the same procedures used in Example 1 were repeated except that rice starch (WR-1) and corn starch (purified, dried and sterilized corn starch) were, respectively, substituted for the acid-decomposed waxy corn starch (WS-10) used in the composition of Example 1 having a composition as specified in Table 2 to thus form a capsule. As a result, it was found that even when adding 40 to 110 parts of pure water, the compositions of Comparative Examples 1 and 2 had extremely high viscosities to such an extent that the machinery and tools for the preparation thereof were almost broken and that these compositions never permitted the preparation of any film-forming liquid.
Comparative Examples 3 to 5
[0032] In these Comparative Examples 3 to 5, the same procedures used in Example 1 were repeated except that cluster dextrin (derived from waxy corn; Comparative Example 3), enzyme-treated dextrin (Pinedex #100; Comparative Example 4) and enzyme-treated dextrin
(MAX 1000; Comparative Example 5) were, respectively, substituted for the
acid-decomposed waxy corn starch (WS-10) used in the composition of Example 1 whose composition was specified in Table 2 to thus form a capsule.
[0033] The capsules produced in Example 1 and Comparative Examples 3 to 5 were inspected for the film strength and the stability thereof with the lapse of time, according to the following methods.
Burst Test
[0034] Using a burst test machine specified below, a varying load is applied to one capsule to thus determine the load observed when the capsule is just cracked and the load is expressed in the unit kg:
Capsule Size: 9.5 Oblong;
Film Thickness: About 0.5 mm (0.4 to 0.6 mm);
Burst Test Machine: KIYA Type Hardness Meter (1600-E Type, available from Fujiwara Seisakusho, Ltd.) Disintegration Ability
[0035] This physical property was determined according to the disintegration testing method as specified in Japanese Pharmacopoeia, the 14 revised edition. This is expressed in terms of the time period required for initiating the release of the charged medical fluid out of the capsule and that required for the complete dissolution of the capsule film.
[0036] The results are summarized in the following Table 3:
Table 3
Figure imgf000012_0001
[0037] The results listed in the foregoing Table 3 clearly indicate that the soft capsule (Example 1) produced using the film-forming composition for soft capsules according to the present invention has a very high physical strength as determined in the burst test as compared with those observed for the capsules prepared in Comparative Examples 3 to 5, but there is not observed any substantial difference in the disintegration time between the capsule prepared in Example 1 and those prepared in Comparative Examples 3 to 5.
[0038] Moreover, the same tests were carried out after each of the capsules was stored at 40°C over 3 months. The results obtained are summarized in the following Table 4. The data listed in Table 4 clearly indicate that the capsule of the present invention still maintains its excellent physical strength and disintegration time.
[0039] The capsules prepared in Comparative Examples 3 to 5 showed the deterioration of the physical strength after the storage thereof at 40°C, while the capsule prepared in Example 1 did not show any deterioration of the physical strength even after the storage thereof at 40°C.
Table 4
Figure imgf000013_0001
[0040] In addition, the capsules produced in Example 1 and Comparative Examples 3 to 5 were inspected for the characteristic properties such as the appearance of the soft capsules. The results thus obtained are summarized in the following Table 5.
Table 5: Quality of Capsules
Figure imgf000013_0002
[0041] As will be seen from the data listed in Table 5, the soft capsule (Example 1) produced using the film-forming composition for soft capsules according to the present invention was found to be excellent in all of the properties tested, or the odor, taste, color and lack of clumping, while the capsule prepared in Comparative Example 3 gives out a strong odor of caramel and has a taste of caramel. Accordingly, a problem arises such that the odor of caramel may impair the palatability of the capsule when eating the same. The capsule prepared in Comparative Example 4 suffers from such a problem that it has an insufficient transparency and appears to be dark, although it has weak odor and taste of caramel. The capsule prepared in Comparative Example 5 has an insufficient transparency, appears to be dark. Further the capsules prepared in Comparative Example 5 are mutually adhered to one another strongly, causing clumping and a problem thus arises when packaging the same.
Example 2
[0042] The same procedures used in Example 1 were repeated except for using the composition specified in the following Table 6, or the film-forming composition for soft capsules used in Example 1, from which sodium phosphate as a buffering agent was removed, to thus form a soft capsule.
Table 6
Figure imgf000014_0001
[0043] The soft capsule prepared in Example 2 was inspected for the physical strength. The results thus obtained are summarized in the following Table 7 together with those observed for the soft capsule prepared in Example 1, for the purpose of comparison.
Table 7
Figure imgf000015_0001
[0044] As will be seen from the data listed in Table 7, the present invention permits the production of a soft capsule with excellent physical strength without using sodium phosphate as a buffering agent. Moreover, when comparing the results listed in Table 3 with those listed in Table 7, it was found that the capsule prepared in Example 2 has a shorter opening time than that observed for the capsule prepared in Example 1 , and the former has an excellent disintegration rate, which is one of the advantages of the soft capsule.

Claims

WHAT IS CLAIMED IS:
1. A film-forming composition for use in the preparation of a soft capsule, said film-forming composition comprising:
(a) acid-decomposed waxy corn starch;
(b) a gelling agent; and
(c) a plasticizer.
2. The composition as set forth in claim 1, wherein the acid-decomposed waxy corn starch has a viscosity ranging from about 5 to about 100 mPa · S as determined using a 20% by mass aqueous solution thereof at 80°C.
3. The composition as set forth in claim 1 , wherein the gelling agent is carrageenan.
4. The composition as set forth in claim 1, wherein the plasticizer is glycerin, sorbitol, polyethylene glycol or a mixture thereof.
5. The composition as set forth in claim 1, further comprising (d) a buffering agent.
6. The composition as set forth in claim 5, wherein the buffering agent is a sodium salt, a potassium salt or a calcium salt.
7. The composition as set forth in claim 1, wherein the composition is free of any buffering agent.
8. A soft capsule shell made using the film-forming composition of claim 1.
9. A soft capsule comprising the shell of claim 8 and a capsule-filling material accommodated within the shell.
PCT/US2010/044419 2010-08-04 2010-08-04 Film-forming composition for soft capsules WO2012018329A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
BR112013002721A BR112013002721B8 (en) 2010-08-04 2010-08-04 film-forming composition for soft capsules, soft capsules and their shell
US13/814,168 US20130189522A1 (en) 2010-08-04 2010-08-04 Film-forming composition for soft capsules
EP10855698.6A EP2600849B1 (en) 2010-08-04 2010-08-04 Film-forming composition for soft capsules
CA2807314A CA2807314C (en) 2010-08-04 2010-08-04 Film-forming composition for soft capsules
KR1020127015423A KR101288079B1 (en) 2010-08-04 2010-08-04 Film-forming composition for soft capsules
MX2013001311A MX344742B (en) 2010-08-04 2010-08-04 Film-forming composition for soft capsules.
PCT/US2010/044419 WO2012018329A1 (en) 2010-08-04 2010-08-04 Film-forming composition for soft capsules
AU2010358565A AU2010358565B2 (en) 2010-08-04 2010-08-04 Film-forming composition for soft capsules
CN201080069480.7A CN103228269B (en) 2010-08-04 2010-08-04 Film-forming composition for soft capsules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2010/044419 WO2012018329A1 (en) 2010-08-04 2010-08-04 Film-forming composition for soft capsules

Publications (1)

Publication Number Publication Date
WO2012018329A1 true WO2012018329A1 (en) 2012-02-09

Family

ID=45559704

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/044419 WO2012018329A1 (en) 2010-08-04 2010-08-04 Film-forming composition for soft capsules

Country Status (9)

Country Link
US (1) US20130189522A1 (en)
EP (1) EP2600849B1 (en)
KR (1) KR101288079B1 (en)
CN (1) CN103228269B (en)
AU (1) AU2010358565B2 (en)
BR (1) BR112013002721B8 (en)
CA (1) CA2807314C (en)
MX (1) MX344742B (en)
WO (1) WO2012018329A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014209964A1 (en) * 2013-06-25 2014-12-31 R.P. Scherer Technologies, Llc Shell-forming compositions for soft capsules and soft capsules
US9408858B2 (en) 2007-04-25 2016-08-09 Opko Renal, Llc Method for treating secondary hyperparathyroidism in CKD
US9861644B2 (en) 2013-03-15 2018-01-09 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US9943530B2 (en) 2006-02-03 2018-04-17 Opko Renal, Llc Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US10302660B2 (en) 2008-04-02 2019-05-28 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
US10668089B2 (en) 2006-06-21 2020-06-02 Opko Ireland Global Holdings, Ltd. Method of treating and preventing secondary hyperparathyroidism
US11173168B2 (en) 2016-03-28 2021-11-16 Eirgen Pharma Ltd. Methods of treating vitamin D insufficiency in chronic kidney disease
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
US11801253B2 (en) 2007-04-25 2023-10-31 Opko Renal, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103893771B (en) 2014-04-21 2015-08-26 湖南尔康制药股份有限公司 A kind of film-forming composition for the production of starch material soft capsule and preparation method thereof
US20170292011A1 (en) * 2014-10-03 2017-10-12 Fuji Capsule Co., Ltd. Soft capsule shell
KR101675438B1 (en) 2015-12-18 2016-11-11 김문구 Composition for preparing soft capsule shell
US10711119B2 (en) * 2018-01-10 2020-07-14 Cp Kelco Aps Carrageenan-based compositions for films and capsules
CN109908102B (en) * 2018-12-28 2019-12-27 中国科学院化学研究所 Shell forming composition for preparing plant soft capsules and method for preparing soft capsules
CN116531343B (en) * 2023-05-16 2023-12-01 秦皇岛稷中食品有限公司 Gelling composition containing carrageenan and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214376B1 (en) * 1998-08-25 2001-04-10 Banner Pharmacaps, Inc. Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
US6375981B1 (en) * 2000-06-01 2002-04-23 A. E. Staley Manufacturing Co. Modified starch as a replacement for gelatin in soft gel films and capsules
US20050196436A1 (en) * 2004-03-02 2005-09-08 Arjnarong Chantranukul Blends of different acyl gellan gums and starch
US20080138402A1 (en) * 2006-11-17 2008-06-12 Zhixin Li Highly inhibited starch fillers for films and capsules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1105107T1 (en) * 1999-07-07 2007-04-30 Scherer Technologies Inc R P Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6528088B1 (en) * 2000-06-01 2003-03-04 A. E. Staley Manufacturing Co. Highly flexible starch-based films
US8231896B2 (en) * 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
CN101203551B (en) * 2005-06-16 2011-09-28 日本合成化学工业株式会社 Water-solubility membrane

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214376B1 (en) * 1998-08-25 2001-04-10 Banner Pharmacaps, Inc. Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
US6375981B1 (en) * 2000-06-01 2002-04-23 A. E. Staley Manufacturing Co. Modified starch as a replacement for gelatin in soft gel films and capsules
US20050196436A1 (en) * 2004-03-02 2005-09-08 Arjnarong Chantranukul Blends of different acyl gellan gums and starch
US20080138402A1 (en) * 2006-11-17 2008-06-12 Zhixin Li Highly inhibited starch fillers for films and capsules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2600849A4 *

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11911398B2 (en) 2006-02-03 2024-02-27 Opko Renal, Llc Treating Vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US11007204B2 (en) 2006-02-03 2021-05-18 Opko Renal, Llc Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US10213442B2 (en) 2006-02-03 2019-02-26 Opko Renal, Llc Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US9943530B2 (en) 2006-02-03 2018-04-17 Opko Renal, Llc Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US10668089B2 (en) 2006-06-21 2020-06-02 Opko Ireland Global Holdings, Ltd. Method of treating and preventing secondary hyperparathyroidism
US9925147B2 (en) 2007-04-25 2018-03-27 Opko Renal, Llc Method for treating secondary hyperparathyroidism in CKD
US11154509B2 (en) 2007-04-25 2021-10-26 Eirgen Pharma Ltd. Methods for controlled release oral dosage of a vitamin D compound
US9918940B2 (en) 2007-04-25 2018-03-20 Opko Renal, Llc Methods for controlled release oral dosage of a vitamin D compound
US9498486B1 (en) 2007-04-25 2016-11-22 Opko Renal, Llc Method for controlled release oral dosage of a vitamin D compound
US9408858B2 (en) 2007-04-25 2016-08-09 Opko Renal, Llc Method for treating secondary hyperparathyroidism in CKD
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
US11801253B2 (en) 2007-04-25 2023-10-31 Opko Renal, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
US10302660B2 (en) 2008-04-02 2019-05-28 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
US9861644B2 (en) 2013-03-15 2018-01-09 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US10350224B2 (en) 2013-03-15 2019-07-16 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US10357502B2 (en) 2013-03-15 2019-07-23 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US11253528B2 (en) 2013-03-15 2022-02-22 Eirgen Pharma Ltd. Stabilized modified release Vitamin D formulation and method of administering same
US10300078B2 (en) 2013-03-15 2019-05-28 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
WO2014209964A1 (en) * 2013-06-25 2014-12-31 R.P. Scherer Technologies, Llc Shell-forming compositions for soft capsules and soft capsules
US9814683B2 (en) 2013-06-25 2017-11-14 R.P. Scherer Technologies, Llc Shell-forming compositions for soft capsules and soft capsules
EP3013326A4 (en) * 2013-06-25 2016-07-06 Rp Scherer Technologies Llc Shell-forming compositions for soft capsules and soft capsules
CN105338971A (en) * 2013-06-25 2016-02-17 R.P.谢勒技术有限公司 Shell-forming compositions for soft capsules and soft capsules
JP2015007008A (en) * 2013-06-25 2015-01-15 アール.ピー. シェーラー テクノロジーズ エルエルシー Shell formation composition for soft capsules, and soft capsule
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11007205B2 (en) 2014-08-07 2021-05-18 Eirgen Pharma Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US10493084B2 (en) 2014-08-07 2019-12-03 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11738033B2 (en) 2014-08-07 2023-08-29 Eirgen Pharma Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11173168B2 (en) 2016-03-28 2021-11-16 Eirgen Pharma Ltd. Methods of treating vitamin D insufficiency in chronic kidney disease

Also Published As

Publication number Publication date
EP2600849B1 (en) 2016-03-30
US20130189522A1 (en) 2013-07-25
BR112013002721B8 (en) 2021-05-25
CA2807314A1 (en) 2012-02-09
AU2010358565B2 (en) 2016-07-14
CN103228269B (en) 2015-06-17
KR20120128602A (en) 2012-11-27
MX344742B (en) 2017-01-05
KR101288079B1 (en) 2013-07-22
CA2807314C (en) 2017-06-20
EP2600849A4 (en) 2014-01-15
MX2013001311A (en) 2013-03-18
CN103228269A (en) 2013-07-31
AU2010358565A1 (en) 2013-02-14
BR112013002721B1 (en) 2020-12-15
BR112013002721A2 (en) 2016-05-31
EP2600849A1 (en) 2013-06-12

Similar Documents

Publication Publication Date Title
AU2010358565B2 (en) Film-forming composition for soft capsules
JP4763590B2 (en) Film-forming composition containing modified starch and iota-carrageenan and method for producing soft capsules using the same
EP0946637B1 (en) Polymer film compositions for capsules
US6649180B1 (en) Hard capsule formed of cellulose ether film with a specific content of methoxyl and hydroxypropoxyl groups
JP4797211B2 (en) Film forming composition for soft capsule
JPH08208458A (en) Coating film composition for capsule
CN109908103B (en) Composition for preparing plant soft capsules
EP1072633A1 (en) Pullulan film compositions
JP5334727B2 (en) Soft capsule manufacturing method
KR20130104939A (en) Soft capsule film composition using starch as main base material
JP5021263B2 (en) Film composition
JP6698335B2 (en) Film-forming composition for soft capsule
EP1598062A1 (en) Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
AU769004B2 (en) Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
AU2004201566A1 (en) Film Forming Compositions Comprising Modified Starches and Iota-carrageenan and Methods for Manufacturing Soft Capsules Using Same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10855698

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 20127015423

Country of ref document: KR

Kind code of ref document: A

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: MX/A/2013/001311

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2807314

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2010358565

Country of ref document: AU

Date of ref document: 20100804

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2010855698

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13814168

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013002721

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013002721

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130204